Competency: 7

Details

Prepare a range of diagnostic clinical reports for a lung cancer patient.

Considerations

• How to recognise all tests have been completed to a satisfactory standard for the referral reason.
• All information has been validated as correct. Selection of correct report template for referral reason.
• Recommendations for further referral (e.g. clinical genetics). Identify the requirements for any follow up testing, the testing methods available and the appropriate choice of test. Describe any limitations.
• Use of correct scientific terminology and nomenclature (e.g. HGVS).
• Communication of complex scientific information to clinicians and patients.
• Recommendation of suitable potential therapeutics including personalized medicine e.g. Monoclonal Antibody therapy, Tyrosine kinase inhibitor therapy (primary and secondary), Clinical trials, NICE and Cancer Drug Fund
• The importance of sensitising and resistant mutation
• Best practice guidelines compared with laboratory practice and any differences between the two.
• How to identify pertinent EQA schemes; their role and practice; how these are incorporated into laboratory practice; ISO standards for lab participation in EQA schemes.
• The calculation of residual probability following molecular testing where appropriate.
• Use of relevant databases and the literature in the interpretation of results.
• Pathways for obtaining further suitable samples

Relevant learning outcomes